# Electronic Import Entries; Technical Amendments
> **Food and Drug Administration** · Final rule; technical amendments. · Published 2021-04-01 · Effective 2021-04-01 · 86 FR 17059
## Document
- **Document number:** 2021-06679
- **Category:** hospital-facility
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 86 FR 17059
- **CFR reference:** 21 CFR 1
- **Publication date:** 2021-04-01
- **Effective date:** 2021-04-01
- **HHS docket:** Docket No. FDA-2016-N-1487
## Abstract

The Food and Drug Administration (FDA, the Agency, or we) is amending its electronic import entries regulation to correct the statutory citation in the sections of that regulation requiring submission of the Drug Registration Number for human drugs and for animal drugs. The present revisions are necessary to correct editorial errors and to ensure that the codified cites the correct section of the Federal Food, Drug, and Cosmetic Act (FD&C Act). The electronic import entries regulation provides that the Drug Registration Number, which must be submitted at the time of entry in the Automated Commercial Environment (ACE) or any other electronic data interchange (EDI) system authorized by the U.S. Customs and Border Protection Agency (CBP), is the unique facility identifier specified in the FD&C Act. This rule does not impose any new regulatory requirements on affected parties. This action is editorial in nature and is intended to improve the accuracy of the Agency's regulations.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2021/04/01/2021-06679/electronic-import-entries-technical-amendments)
---
*AI Analytics · CC0 1.0*